Market revenue in 2022 | USD 111.0 million |
Market revenue in 2030 | USD 237.4 million |
Growth rate | 10% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 51.98% in 2022. Horizon Databook has segmented the Spain non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the market is driven by increasing incidence of Down syndrome, improving healthcare infrastructure, and rising consumer awareness. Consolidating laboratories is a growing trend in this market. This strategic move will not only enable the scaling-up of businesses but will also help companies expand their market presence.
There is no national NIPT policy in place in Spain. Some areas, including the province of Madrid, have chosen to provide NIPT to people at high risk. In other areas without official programs, several hospitals have implemented NIPT in accordance with their requirements and budget, and in these instances, NIPT is publicly funded.
The percentage of women receiving NIPT in Spain is significant due to the widespread usage of NIPT in the private sector (25%- 50%). In addition, government initiatives are likely to spread awareness about NIPT in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into Spain non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account